MAGE-A4-targeted TCR-T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MAGE-A4-targeted TCR-T cell therapy, covering 2026-03-12 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Exploratory Clinical Study of TCR-T for MAGE-A4-positive Mesenchymal Malignancies [Phase 1]